However, of those with positive ACPA, nearly half went on to develop RA. While RF and ACPA testing had limited yield in the setting of PTLD, those with positive serologies should be monitored closely for the development of an inflammatory arthritis. This evidence concerns the gene PRTN3 and rheumatoid arthritis.